Table of Contents
Preface |
vii |
|
1 |
Psychiatric History and Mental Status Examination |
1 |
2 |
Physical Illness and Psychiatric Disorder |
10 |
3 |
Laboratory Tests in Psychiatry |
16 |
4 |
Signs and Symptoms in Psychiatry |
21 |
5 |
Classification in Psychiatry |
33 |
6 |
Psychiatric Rating Scales |
40 |
7 |
Delirium, Dementia, Amnestic, and Other Cognitive
Disorders and Mental Disorders Due to a General Medical Condition |
46 |
7.1 |
Overview |
46 |
7.2 |
Delirium |
48 |
7.3 |
Dementia |
52 |
7.4 |
Amnestic Disorders |
60 |
7.5 |
Mental Disorders Due to a General Medical
Condition |
65 |
8 |
Neuropsychiatric Aspects of HIV Infection and
AIDS |
80 |
9 |
Substance-Related Disorders |
85 |
9.1 |
Introduction and Overview |
85 |
9.2 |
Alcohol-Related Disorders |
90 |
9.3 |
Amphetamine (or Amphetamine-Like)-Related
Disorders |
105 |
9.4 |
Caffeine-Related Disorders |
110 |
9.5 |
Cannabis-Related Disorders |
114 |
9.6 |
Cocaine-Related Disorders |
117 |
9.7 |
Hallucinogen-Related Disorders |
123 |
9.8 |
Inhalant-Related Disorders |
129 |
9.9 |
Nicotine-Related Disorders |
132 |
9.10 |
Opioid-Related Disorders |
136 |
9.11 |
Phencyclidine (or Phencyclidine-Like)-Related
Disorders |
142 |
9.12 |
Sedative-, Hypnotic-, or Anxiolytic-Related
Disorders |
145 |
9.13 |
Anabolic-Androgenic Steroid Abuse |
150 |
9.14 |
Other Substance-Related Disorders |
152 |
10 |
Schizophrenia |
156 |
11 |
Other Psychotic Disorders |
178 |
11.1 |
Schizophreniform Disorder |
178 |
11.2 |
Schizoaffective Disorder |
180 |
11.3 |
Delusional Disorder and Shared Psychotic Disorder |
182 |
11.4 |
Brief Psychotic Disorder, Psychotic Disorder Not
Otherwise Specified, and Secondary Psychotic Disorders |
190 |
11.5 |
Culture-Bound Syndromes |
195 |
12 |
Mood Disorders |
200 |
12.1 |
Depression and Bipolar Disorder |
200 |
12.2 |
Dysthymia and Cyclothymia |
225 |
12.3 |
Other Mood Disorders |
230 |
13 |
Anxiety Disorders |
236 |
13.1 |
Overview |
236 |
13.2 |
Panic Disorder and Agoraphobia |
239 |
13.3 |
Specific Phobia and Social Phobia |
247 |
13.4 |
Obsessive-Compulsive Disorder |
253 |
13.5 |
Posttraumatic Stress Disorder and Acute Stress
Disorder |
258 |
13.6 |
Generalized Anxiety Disorder |
263 |
13.7 |
Other Anxiety Disorders |
267 |
14 |
Somatoform Disorders |
273 |
15 |
Factitious Disorders |
287 |
16 |
Dissociative Disorders |
293 |
17 |
Human Sexuality |
303 |
17.1 |
Normal Sexuality |
303 |
17.2 |
Abnormal Sexuality and Sexual Dysfunctions |
306 |
17.3 |
Paraphilias and Sexual Disorder Not
Otherwise Specified |
318 |
18 |
Gender Identity Disorders |
326 |
19 |
Eating Disorders |
333 |
19.1 |
Anorexia Nervosa |
333 |
19.2 |
Bulimia Nervosa and Eating Disorder Not Otherwise
Specified |
338 |
19.3 |
Obesity |
341 |
20 |
Normal Sleep and Sleep Disorders |
346 |
20.1 |
Normal Sleep |
346 |
20.2 |
Sleep Disorders |
348 |
21 |
Impulse-Control Disorders Not Elsewhere Classified |
360 |
22 |
Adjustment Disorders |
371 |
23 |
Personality Disorders |
375 |
24 |
Psychosomatic Medicine |
393 |
25 |
Consultation-Liaison Psychiatry |
400 |
26 |
Psychiatry and Reproductive Medicine |
403 |
27 |
Relational Problems |
410 |
28 |
Problems Related to Abuse or Neglect |
414 |
29 |
Additional Conditions that may be a Focus of
Clinical Attention |
421 |
30 |
Emergency Psychiatric Medicine |
428 |
30.1 |
Suicide |
428 |
30.2 |
Other Psychiatric Emergencies |
434 |
31 |
Psychotherapies |
445 |
31.1 |
Psychoanalysis and Psychoanalytic Psychotherapy |
445 |
31.2 |
Brief Psychodynamic Psychotherapy |
449 |
31.3 |
Group Psychotherapy, Combined Individual and
Group Psychotherapy, and Psychodrama |
451 |
31.4 |
Family Therapy and Couples Therapy |
454 |
31.5 |
Dialectical Behavior Therapy |
456 |
31.6 |
Genetic Counseling |
457 |
31.7 |
Biofeedback |
457 |
31.8 |
Behavior Therapy |
458 |
31.9 |
Cognitive Therapy |
461 |
31.10 |
Hypnosis |
463 |
31.11 |
Interpersonal Therapy |
464 |
31.12 |
Psychiatric Rehabilitation |
466 |
32 |
Biological Therapies |
468 |
32.1 |
General Principles of Psychopharmacology |
468 |
32.2 |
Medication-Induced Movement Disorders |
472 |
32.3 |
α2-Adrenergic Receptor Agonists: Clonidine
and Guanfacine |
475 |
32.4 |
ß-Adrenergic Receptor Antagonists |
477 |
32.5 |
Anticholinergics and Amantadine |
479 |
32.6 |
Anticonvulsants: Gabapentin,
Pregabalin, Tiagabine, Levetiracetam,
Topiramate,
and Zonisamide |
481 |
32.7 |
Antihistamines |
483 |
32.8 |
Barbiturates and Similarly Acting Drugs |
485 |
32.9 |
Benzodiazepines and Drugs Acting on
Benzodiazepine Receptors |
488 |
32.10 |
Bupropion |
492 |
32.11 |
Buspirone |
494 |
32.12 |
Calcium Channel Inhibitors |
495 |
32.13 |
Carbamazepine and Oxcarbazepine |
496 |
32.14 |
Cholinesterase Inhibitors and Memantine |
499 |
32.15 |
Dantrolene |
502 |
32.16 |
Disulfiram and Acamprosate |
502 |
32.17 |
Dopamine Receptor Agonists and Precursors: Apomorphine,
Bromocriptine,
Levodopa,
Pergolide,
Pramipexole,
and Ropinirole |
504 |
32.18 |
Dopamine Receptor Antagonists: Typical
Antipsychotics |
506 |
32.19 |
Lamotrigine |
513 |
32.20 |
Lithium |
514 |
32.21 |
Melatonin Agonists: Ramelteon and Melatonin |
519 |
32.22 |
Mirtazapine |
520 |
32.23 |
Monoamine Oxidase Inhibitors |
521 |
32.24 |
Nefazodone |
524 |
32.25 |
Opioid Receptor Agonists: Methadone, Buprenorphine,
and Levomethadyl |
526 |
32.26 |
Opioid Receptor Antagonists: Naltrexone,
Nalmefene,
and Naloxone |
528 |
32.27 |
Phosphodiesterase-5 Inhibitors |
531 |
32.28 |
Selective Serotonin-Norepinephrine
Reuptake Inhibitors |
533 |
32.29 |
Selective Serotonin Reuptake Inhibitors |
535 |
32.30 |
Serotonin-Dopamine Antagonists: Atypical
Antipsychotics |
542 |
32.31 |
Sympathomimetics and Related Drugs |
548 |
32.32 |
Thyroid Hormones |
552 |
32.33 |
Trazodone |
554 |
32.34 |
Tricyclics and Tetracyclics |
555 |
32.35 |
Valproate |
559 |
32.36 |
Yohimbine |
561 |
32.37 |
Electroconvulsive Therapy |
562 |
32.38 |
Other Brain Stimulation Methods |
566 |
33 |
Child Psychiatry: Assessment, Examination, and
Psychological Testing |
568 |
34 |
Mental Retardation |
575 |
35 |
Learning Disorders |
585 |
36 |
Motor Skills Disorder: Developmental Coordination
Disorder |
592 |
37 |
Communication Disorders |
595 |
38 |
Pervasive Developmental Disorders |
605 |
39 |
Attention-Deficit Disorders |
616 |
40 |
Disruptive Behavior Disorders: Oppositional
Defiant Disorder and Conduct Disorder |
623 |
41 |
Feeding and Eating Disorders of Infancy or Early
Childhood |
629 |
42 |
Tic Disorders |
634 |
43 |
Elimination Disorders |
639 |
44 |
Other Disorders of Infancy, Childhood, and
Adolescence |
644 |
44.1 |
Reactive Attachment Disorder of Infancy or Early
Childhood |
644 |
44.2 |
Stereotypic Movement Disorder and Disorder of
Infancy, Childhood, or Adolescence Not Otherwise Specified |
646 |
45 |
Mood Disorders and Suicide in Children and
Adolescents |
650 |
45.1 |
Depressive Disorders and Suicide in Children and
Adolescents |
650 |
45.2 |
Early-Onset Bipolar Disorders |
656 |
46 |
Anxiety Disorders of Infancy, Childhood, and
Adolescence |
659 |
46.1 |
Obsessive-Compulsive Disorder of Infancy,
Childhood, and Adolescence |
659 |
46.2 |
Separation Anxiety Disorder, Generalized Anxiety
Disorder, and Social Phobia |
662 |
46.3 |
Selective Mutism |
667 |
47 |
Early-Onset Schizophrenia |
669 |
48 |
Child Psychiatry: Additional Conditions that may
be a Focus of Clinical Attention |
673 |
49 |
Psychiatric Treatment of Children and Adolescents |
679 |
49.1 |
Individual Psychotherapy |
679 |
49.2 |
Group Psychotherapy |
682 |
49.3 |
Residential, Day, and Hospital Treatment |
684 |
49.4 |
Biological Therapies |
686 |
49.5 |
Psychiatric Treatment of Adolescents |
690 |
50 |
Geriatric Psychiatry |
694 |
51 |
End of Life Care |
698 |
51.1 |
Palliative Care |
698 |
51.2 |
Euthanasia and Physician-Assisted Suicide |
700 |
52 |
Clinical-Legal Issues in Psychiatry |
703 |
53 |
Ethics in Psychiatry |
709 |
Index |
712 |
|